News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,169 Results
Type
Article (5007)
Company Profile (17)
Press Release (218145)
Section
Business (82199)
Career Advice (461)
Deals (15044)
Drug Delivery (8)
Drug Development (19060)
Employer Resources (30)
FDA (3674)
Job Trends (3899)
News (120103)
Policy (7501)
Tag
Academia (290)
Alliances (14748)
Alzheimer's disease (226)
Approvals (3680)
Artificial intelligence (31)
Bankruptcy (96)
Best Places to Work (2862)
Breast cancer (40)
Cancer (347)
Career advice (391)
Cell therapy (81)
Clinical research (15876)
Collaboration (126)
Compensation (117)
COVID-19 (298)
C-suite (70)
Data (384)
Diabetes (32)
Diagnostics (2017)
Earnings (40154)
Employer resources (31)
Events (37357)
Executive appointments (230)
FDA (3852)
Funding (146)
Gene therapy (36)
GLP-1 (100)
Government (406)
Healthcare (5028)
Infectious disease (310)
Inflammatory bowel disease (23)
Interviews (53)
IPO (7792)
Job creations (1121)
Job search strategy (360)
Layoffs (97)
Legal (2327)
Lung cancer (39)
Manufacturing (40)
Medical device (3838)
Medtech (3839)
Mergers & acquisitions (7388)
Metabolic disorders (97)
Neuroscience (295)
NextGen: Class of 2025 (1672)
Non-profit (729)
Northern California (697)
Obesity (47)
Opinion (29)
People (24373)
Phase I (4736)
Phase II (6909)
Phase III (5477)
Pipeline (323)
Postmarket research (625)
Preclinical (1845)
Press Release (66)
Radiopharmaceuticals (105)
Rare diseases (57)
Real estate (1870)
Regulatory (5043)
Research institute (298)
Resumes & cover letters (68)
Southern California (520)
Startups (1007)
United States (5469)
Vaccines (29)
Date
Today (11)
Last 7 days (193)
Last 30 days (668)
Last 365 days (10750)
2025 (947)
2024 (11028)
2023 (13193)
2022 (18659)
2021 (19684)
2020 (18243)
2019 (13206)
2018 (10206)
2017 (10008)
2016 (9161)
2015 (12119)
2014 (9592)
2013 (7708)
2012 (8329)
2011 (8796)
2010 (8636)
Location
Africa (183)
Arizona (52)
Asia (11361)
Australia (1583)
California (1456)
Canada (574)
China (45)
Colorado (64)
Connecticut (75)
Europe (24207)
Florida (198)
Georgia (27)
Illinois (95)
Indiana (47)
Japan (49)
Kansas (24)
Maine (36)
Maryland (174)
Massachusetts (1196)
Michigan (76)
Minnesota (118)
New Jersey (435)
New York (377)
North Carolina (274)
Northern California (697)
Ohio (44)
Pennsylvania (279)
South America (274)
Southern California (520)
Texas (174)
Utah (46)
Virginia (29)
Washington State (130)
223,169 Results for "mannkind corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
Pulmatrix, Inc. announced a series of transactions with MannKind Corporation.
May 29, 2024
·
6 min read
Biotech Beach
MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
MannKind Corporation announced that it has agreed to in-license iSPERSE™ technology from Pulmatrix for certain indications in exchange for an out-license of MannKind’s Cricket® inhaler to Pulmatrix for inhaled delivery of dihydroergotamine for migraine treatment.
May 29, 2024
·
4 min read
Business
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development UpdateConference Call to Begin Today at 5:00 p.m. (ET)
MannKind Corporation reported financial results for the quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Business
MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
MannKind Corporation (Nasdaq: MNKD) will release its 2024 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 8, 2024.
May 1, 2024
·
1 min read
Press Releases
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
November 8, 2024
·
19 min read
Press Releases
MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
November 1, 2024
·
1 min read
Press Releases
MannKind to Present at 2024 UBS Healthcare Conference
November 6, 2024
·
1 min read
Business
MannKind Announces CFO Transition - March 26, 2024
MannKind Corporation announced that Steven B. Binder will retire from his position as Chief Financial Officer, effective April 22, 2024.
March 26, 2024
·
5 min read
Drug Development
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
MannKind Corporation announced that it will proceed with a first-in-human Phase 1 study of nintedanib DPI for pulmonary fibrotic diseases, including idiopathic pulmonary fibrosis.
April 30, 2024
·
4 min read
Business
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
MannKind Corporation will release its 2023 fourth quarter and full year financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM on Tuesday, February 27, 2024.
February 20, 2024
·
1 min read
1 of 22,317
Next
